Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Comparing the reproductive outcomes of intracytoplasmic sperm injection (ICSI) cycles in
women at risk of ovarian hyperstimulation syndrome (OHSS) subjected to gonadotropin releasing
hormone (GnRH) antagonist protocol followed by trigger with concomitant GnRH agonist (GnRHa)
and low-dose human chorionic gonadotropin (HCG) administration (dual trigger), GnRHa trigger
with single luteal low-dose HCG or GnRHa trigger with multiple luteal low-doses HCG